« Back to Record
Agostinetto, E., Papagiannis, A., Cailleux, F., Brandão, M., Stanciu, M.-A., Larsimont, D., Veys, I., Paesmans, M., Besse-Hammer, T., Awada, A., Piccart-Gebhart, M., Sotiriou, C., Ameye, L., Neven, P., Duhoux, F. P., Vuylsteke, P., & Ignatiadis, M. (2023). Primary efficacy analyses of NeoRHEA, neoadjuvant biomarker research study of palbociclib combined with endocrine therapy in estrogen receptor positive/HER2 negative breast cancer. Journal of clinical oncology, 41(16_suppl), 522-522. doi:10.1200/JCO.2023.41.16_suppl.522
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/401716



